nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoniazid—NAT2—breast cancer	0.296	0.718	CbGaD
Isoniazid—CYP2D6—breast cancer	0.0625	0.152	CbGaD
Isoniazid—CYP2A6—Letrozole—breast cancer	0.058	0.139	CbGbCtD
Isoniazid—CYP3A4—breast cancer	0.0536	0.13	CbGaD
Isoniazid—CYP1A2—Anastrozole—breast cancer	0.0197	0.0471	CbGbCtD
Isoniazid—CYP1A2—Toremifene—breast cancer	0.0181	0.0431	CbGbCtD
Isoniazid—CYP2C9—Anastrozole—breast cancer	0.0178	0.0425	CbGbCtD
Isoniazid—CYP2A6—Tamoxifen—breast cancer	0.0173	0.0413	CbGbCtD
Isoniazid—CYP2C8—Lapatinib—breast cancer	0.017	0.0406	CbGbCtD
Isoniazid—CYP2C19—Lapatinib—breast cancer	0.0143	0.0341	CbGbCtD
Isoniazid—CYP3A4—Exemestane—breast cancer	0.0136	0.0326	CbGbCtD
Isoniazid—CYP2C9—Idarubicin—breast cancer	0.0135	0.0322	CbGbCtD
Isoniazid—CYP2C8—Raloxifene—breast cancer	0.0129	0.0308	CbGbCtD
Isoniazid—CYP2A6—Fluorouracil—breast cancer	0.0127	0.0304	CbGbCtD
Isoniazid—CYP2D6—Idarubicin—breast cancer	0.0123	0.0294	CbGbCtD
Isoniazid—CYP3A4—Letrozole—breast cancer	0.0116	0.0277	CbGbCtD
Isoniazid—CYP2E1—Tamoxifen—breast cancer	0.0114	0.0272	CbGbCtD
Isoniazid—CYP2E1—Mitoxantrone—breast cancer	0.0111	0.0266	CbGbCtD
Isoniazid—CYP3A4—Anastrozole—breast cancer	0.0103	0.0247	CbGbCtD
Isoniazid—CYP3A4—Toremifene—breast cancer	0.00946	0.0226	CbGbCtD
Isoniazid—CYP3A4—Fulvestrant—breast cancer	0.0088	0.021	CbGbCtD
Isoniazid—CYP2C8—Tamoxifen—breast cancer	0.00852	0.0203	CbGbCtD
Isoniazid—CYP3A4—Thiotepa—breast cancer	0.00784	0.0187	CbGbCtD
Isoniazid—CYP2C9—Capecitabine—breast cancer	0.00739	0.0176	CbGbCtD
Isoniazid—CYP3A4—Ixabepilone—breast cancer	0.00717	0.0171	CbGbCtD
Isoniazid—CYP2C19—Tamoxifen—breast cancer	0.00715	0.0171	CbGbCtD
Isoniazid—CYP3A4—Lapatinib—breast cancer	0.0069	0.0165	CbGbCtD
Isoniazid—CYP2C8—Paclitaxel—breast cancer	0.00663	0.0158	CbGbCtD
Isoniazid—CYP1A2—Tamoxifen—breast cancer	0.0066	0.0158	CbGbCtD
Isoniazid—CYP2C8—Fluorouracil—breast cancer	0.00628	0.015	CbGbCtD
Isoniazid—CYP2D6—Vinorelbine—breast cancer	0.00602	0.0144	CbGbCtD
Isoniazid—CYP2C9—Tamoxifen—breast cancer	0.00594	0.0142	CbGbCtD
Isoniazid—CYP2D6—Tamoxifen—breast cancer	0.00543	0.013	CbGbCtD
Isoniazid—CYP3A4—Raloxifene—breast cancer	0.00523	0.0125	CbGbCtD
Isoniazid—CYP1A2—Fluorouracil—breast cancer	0.00486	0.0116	CbGbCtD
Isoniazid—CYP2C9—Paclitaxel—breast cancer	0.00463	0.011	CbGbCtD
Isoniazid—CYP2C9—Fluorouracil—breast cancer	0.00438	0.0105	CbGbCtD
Isoniazid—CYP3A4—Vinorelbine—breast cancer	0.00383	0.00914	CbGbCtD
Isoniazid—CYP2D6—Vinblastine—breast cancer	0.00371	0.00886	CbGbCtD
Isoniazid—CYP3A4—Tamoxifen—breast cancer	0.00346	0.00825	CbGbCtD
Isoniazid—CYP3A4—Mitoxantrone—breast cancer	0.00337	0.00805	CbGbCtD
Isoniazid—CYP3A4—Paclitaxel—breast cancer	0.00269	0.00642	CbGbCtD
Isoniazid—CYP3A4—Irinotecan—breast cancer	0.00265	0.00634	CbGbCtD
Isoniazid—CYP3A4—Vinblastine—breast cancer	0.00236	0.00563	CbGbCtD
Isoniazid—CYP2D6—Doxorubicin—breast cancer	0.00228	0.00544	CbGbCtD
Isoniazid—CYP3A4—Docetaxel—breast cancer	0.00194	0.00464	CbGbCtD
Isoniazid—CYP3A4—Doxorubicin—breast cancer	0.00145	0.00346	CbGbCtD
Isoniazid—Fatigue—Goserelin—breast cancer	0.00013	0.00135	CcSEcCtD
Isoniazid—Diabetes mellitus—Methotrexate—breast cancer	0.00013	0.00135	CcSEcCtD
Isoniazid—Anorexia—Vinorelbine—breast cancer	0.000129	0.00134	CcSEcCtD
Isoniazid—Asthenia—Chlorambucil—breast cancer	0.000127	0.00132	CcSEcCtD
Isoniazid—Ill-defined disorder—Irinotecan—breast cancer	0.000127	0.00132	CcSEcCtD
Isoniazid—Ill-defined disorder—Mitoxantrone—breast cancer	0.000127	0.00132	CcSEcCtD
Isoniazid—Aplastic anaemia—Doxorubicin—breast cancer	0.000127	0.00131	CcSEcCtD
Isoniazid—Thrombocytopenia—Thiotepa—breast cancer	0.000127	0.00131	CcSEcCtD
Isoniazid—Feeling abnormal—Goserelin—breast cancer	0.000124	0.00129	CcSEcCtD
Isoniazid—Lymphadenopathy—Epirubicin—breast cancer	0.000124	0.00129	CcSEcCtD
Isoniazid—Ill-defined disorder—Gemcitabine—breast cancer	0.000124	0.00128	CcSEcCtD
Isoniazid—Malaise—Irinotecan—breast cancer	0.000123	0.00128	CcSEcCtD
Isoniazid—Malaise—Mitoxantrone—breast cancer	0.000123	0.00128	CcSEcCtD
Isoniazid—Anorexia—Thiotepa—breast cancer	0.000123	0.00128	CcSEcCtD
Isoniazid—Diabetes mellitus—Epirubicin—breast cancer	0.000122	0.00126	CcSEcCtD
Isoniazid—Paraesthesia—Vinorelbine—breast cancer	0.000121	0.00126	CcSEcCtD
Isoniazid—Hepatic function abnormal—Epirubicin—breast cancer	0.000121	0.00126	CcSEcCtD
Isoniazid—Malaise—Gemcitabine—breast cancer	0.00012	0.00125	CcSEcCtD
Isoniazid—Hypersensitivity—Vinblastine—breast cancer	0.00012	0.00124	CcSEcCtD
Isoniazid—Body temperature increased—Goserelin—breast cancer	0.000119	0.00124	CcSEcCtD
Isoniazid—Neuropathy peripheral—Docetaxel—breast cancer	0.000119	0.00123	CcSEcCtD
Isoniazid—Hyperglycaemia—Capecitabine—breast cancer	0.000118	0.00123	CcSEcCtD
Isoniazid—Convulsion—Mitoxantrone—breast cancer	0.000118	0.00123	CcSEcCtD
Isoniazid—Jaundice—Docetaxel—breast cancer	0.000118	0.00122	CcSEcCtD
Isoniazid—Decreased appetite—Vinorelbine—breast cancer	0.000118	0.00122	CcSEcCtD
Isoniazid—Asthenia—Vinblastine—breast cancer	0.000117	0.00121	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Vinorelbine—breast cancer	0.000117	0.00121	CcSEcCtD
Isoniazid—Fatigue—Vinorelbine—breast cancer	0.000117	0.00121	CcSEcCtD
Isoniazid—Hypersensitivity—Tamoxifen—breast cancer	0.000117	0.00121	CcSEcCtD
Isoniazid—Paraesthesia—Thiotepa—breast cancer	0.000116	0.0012	CcSEcCtD
Isoniazid—Discomfort—Irinotecan—breast cancer	0.000115	0.00119	CcSEcCtD
Isoniazid—Discomfort—Mitoxantrone—breast cancer	0.000115	0.00119	CcSEcCtD
Isoniazid—Lymphadenopathy—Doxorubicin—breast cancer	0.000115	0.00119	CcSEcCtD
Isoniazid—Neuropathy peripheral—Capecitabine—breast cancer	0.000115	0.00119	CcSEcCtD
Isoniazid—Jaundice—Capecitabine—breast cancer	0.000114	0.00118	CcSEcCtD
Isoniazid—Hypersensitivity—Melphalan—breast cancer	0.000114	0.00118	CcSEcCtD
Isoniazid—Dyspepsia—Thiotepa—breast cancer	0.000114	0.00118	CcSEcCtD
Isoniazid—Asthenia—Tamoxifen—breast cancer	0.000113	0.00118	CcSEcCtD
Isoniazid—Convulsion—Fluorouracil—breast cancer	0.000113	0.00118	CcSEcCtD
Isoniazid—Vomiting—Chlorambucil—breast cancer	0.000113	0.00117	CcSEcCtD
Isoniazid—Agranulocytosis—Docetaxel—breast cancer	0.000113	0.00117	CcSEcCtD
Isoniazid—Diabetes mellitus—Doxorubicin—breast cancer	0.000113	0.00117	CcSEcCtD
Isoniazid—Decreased appetite—Thiotepa—breast cancer	0.000112	0.00117	CcSEcCtD
Isoniazid—Hepatic function abnormal—Doxorubicin—breast cancer	0.000112	0.00116	CcSEcCtD
Isoniazid—Discomfort—Gemcitabine—breast cancer	0.000112	0.00116	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Thiotepa—breast cancer	0.000112	0.00116	CcSEcCtD
Isoniazid—Feeling abnormal—Vinorelbine—breast cancer	0.000111	0.00116	CcSEcCtD
Isoniazid—Fatigue—Thiotepa—breast cancer	0.000111	0.00116	CcSEcCtD
Isoniazid—Hypersensitivity—Goserelin—breast cancer	0.000111	0.00115	CcSEcCtD
Isoniazid—Asthenia—Melphalan—breast cancer	0.000111	0.00115	CcSEcCtD
Isoniazid—Discomfort—Fluorouracil—breast cancer	0.00011	0.00114	CcSEcCtD
Isoniazid—Agranulocytosis—Capecitabine—breast cancer	0.000109	0.00113	CcSEcCtD
Isoniazid—Thrombocytopenia—Irinotecan—breast cancer	0.000109	0.00113	CcSEcCtD
Isoniazid—Thrombocytopenia—Mitoxantrone—breast cancer	0.000109	0.00113	CcSEcCtD
Isoniazid—Hepatitis—Docetaxel—breast cancer	0.000109	0.00113	CcSEcCtD
Isoniazid—Asthenia—Goserelin—breast cancer	0.000108	0.00112	CcSEcCtD
Isoniazid—Body temperature increased—Vinorelbine—breast cancer	0.000107	0.00111	CcSEcCtD
Isoniazid—Feeling abnormal—Thiotepa—breast cancer	0.000106	0.0011	CcSEcCtD
Isoniazid—Thrombocytopenia—Gemcitabine—breast cancer	0.000106	0.0011	CcSEcCtD
Isoniazid—Anorexia—Mitoxantrone—breast cancer	0.000106	0.0011	CcSEcCtD
Isoniazid—Anorexia—Irinotecan—breast cancer	0.000106	0.0011	CcSEcCtD
Isoniazid—Nausea—Chlorambucil—breast cancer	0.000106	0.0011	CcSEcCtD
Isoniazid—Hepatitis—Capecitabine—breast cancer	0.000105	0.00109	CcSEcCtD
Isoniazid—Thrombocytopenia—Fluorouracil—breast cancer	0.000105	0.00109	CcSEcCtD
Isoniazid—Anorexia—Gemcitabine—breast cancer	0.000104	0.00108	CcSEcCtD
Isoniazid—Vomiting—Vinblastine—breast cancer	0.000104	0.00107	CcSEcCtD
Isoniazid—Ill-defined disorder—Paclitaxel—breast cancer	0.000103	0.00107	CcSEcCtD
Isoniazid—Body temperature increased—Thiotepa—breast cancer	0.000102	0.00106	CcSEcCtD
Isoniazid—Anorexia—Fluorouracil—breast cancer	0.000102	0.00106	CcSEcCtD
Isoniazid—Vomiting—Tamoxifen—breast cancer	0.000101	0.00104	CcSEcCtD
Isoniazid—Malaise—Paclitaxel—breast cancer	0.000101	0.00104	CcSEcCtD
Isoniazid—Paraesthesia—Irinotecan—breast cancer	0.0001	0.00104	CcSEcCtD
Isoniazid—Paraesthesia—Mitoxantrone—breast cancer	0.0001	0.00104	CcSEcCtD
Isoniazid—Rash—Tamoxifen—breast cancer	9.97e-05	0.00103	CcSEcCtD
Isoniazid—Hypersensitivity—Vinorelbine—breast cancer	9.97e-05	0.00103	CcSEcCtD
Isoniazid—Vomiting—Melphalan—breast cancer	9.85e-05	0.00102	CcSEcCtD
Isoniazid—Dyspepsia—Irinotecan—breast cancer	9.82e-05	0.00102	CcSEcCtD
Isoniazid—Dyspepsia—Mitoxantrone—breast cancer	9.82e-05	0.00102	CcSEcCtD
Isoniazid—Rash—Melphalan—breast cancer	9.76e-05	0.00101	CcSEcCtD
Isoniazid—Paraesthesia—Gemcitabine—breast cancer	9.76e-05	0.00101	CcSEcCtD
Isoniazid—Asthenia—Vinorelbine—breast cancer	9.71e-05	0.00101	CcSEcCtD
Isoniazid—Decreased appetite—Irinotecan—breast cancer	9.7e-05	0.00101	CcSEcCtD
Isoniazid—Decreased appetite—Mitoxantrone—breast cancer	9.7e-05	0.00101	CcSEcCtD
Isoniazid—Eosinophilia—Methotrexate—breast cancer	9.68e-05	0.001	CcSEcCtD
Isoniazid—Nausea—Vinblastine—breast cancer	9.67e-05	0.001	CcSEcCtD
Isoniazid—Convulsion—Paclitaxel—breast cancer	9.66e-05	0.001	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Irinotecan—breast cancer	9.63e-05	0.001	CcSEcCtD
Isoniazid—Fatigue—Mitoxantrone—breast cancer	9.62e-05	0.000998	CcSEcCtD
Isoniazid—Fatigue—Irinotecan—breast cancer	9.62e-05	0.000998	CcSEcCtD
Isoniazid—Vomiting—Goserelin—breast cancer	9.6e-05	0.000997	CcSEcCtD
Isoniazid—Paraesthesia—Fluorouracil—breast cancer	9.6e-05	0.000996	CcSEcCtD
Isoniazid—Rash—Goserelin—breast cancer	9.52e-05	0.000988	CcSEcCtD
Isoniazid—Hypersensitivity—Thiotepa—breast cancer	9.52e-05	0.000988	CcSEcCtD
Isoniazid—Decreased appetite—Gemcitabine—breast cancer	9.45e-05	0.000981	CcSEcCtD
Isoniazid—Dyspepsia—Fluorouracil—breast cancer	9.41e-05	0.000976	CcSEcCtD
Isoniazid—Nausea—Tamoxifen—breast cancer	9.39e-05	0.000975	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Gemcitabine—breast cancer	9.38e-05	0.000974	CcSEcCtD
Isoniazid—Discomfort—Paclitaxel—breast cancer	9.38e-05	0.000973	CcSEcCtD
Isoniazid—Fatigue—Gemcitabine—breast cancer	9.37e-05	0.000972	CcSEcCtD
Isoniazid—Decreased appetite—Fluorouracil—breast cancer	9.29e-05	0.000964	CcSEcCtD
Isoniazid—Asthenia—Thiotepa—breast cancer	9.27e-05	0.000962	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Fluorouracil—breast cancer	9.23e-05	0.000957	CcSEcCtD
Isoniazid—Nausea—Melphalan—breast cancer	9.2e-05	0.000955	CcSEcCtD
Isoniazid—Feeling abnormal—Mitoxantrone—breast cancer	9.19e-05	0.000954	CcSEcCtD
Isoniazid—Feeling abnormal—Irinotecan—breast cancer	9.19e-05	0.000954	CcSEcCtD
Isoniazid—Eosinophilia—Epirubicin—breast cancer	9.06e-05	0.00094	CcSEcCtD
Isoniazid—Nausea—Goserelin—breast cancer	8.97e-05	0.000931	CcSEcCtD
Isoniazid—Feeling abnormal—Gemcitabine—breast cancer	8.96e-05	0.00093	CcSEcCtD
Isoniazid—Thrombocytopenia—Paclitaxel—breast cancer	8.91e-05	0.000925	CcSEcCtD
Isoniazid—Body temperature increased—Mitoxantrone—breast cancer	8.82e-05	0.000915	CcSEcCtD
Isoniazid—Body temperature increased—Irinotecan—breast cancer	8.82e-05	0.000915	CcSEcCtD
Isoniazid—Feeling abnormal—Fluorouracil—breast cancer	8.81e-05	0.000914	CcSEcCtD
Isoniazid—Anorexia—Paclitaxel—breast cancer	8.67e-05	0.0009	CcSEcCtD
Isoniazid—Vomiting—Vinorelbine—breast cancer	8.6e-05	0.000893	CcSEcCtD
Isoniazid—Body temperature increased—Gemcitabine—breast cancer	8.59e-05	0.000892	CcSEcCtD
Isoniazid—Rash—Vinorelbine—breast cancer	8.53e-05	0.000885	CcSEcCtD
Isoniazid—Ill-defined disorder—Capecitabine—breast cancer	8.49e-05	0.000881	CcSEcCtD
Isoniazid—Body temperature increased—Fluorouracil—breast cancer	8.45e-05	0.000877	CcSEcCtD
Isoniazid—Eosinophilia—Doxorubicin—breast cancer	8.38e-05	0.00087	CcSEcCtD
Isoniazid—Hyperglycaemia—Epirubicin—breast cancer	8.25e-05	0.000856	CcSEcCtD
Isoniazid—Malaise—Capecitabine—breast cancer	8.25e-05	0.000856	CcSEcCtD
Isoniazid—Hypersensitivity—Irinotecan—breast cancer	8.22e-05	0.000853	CcSEcCtD
Isoniazid—Hypersensitivity—Mitoxantrone—breast cancer	8.22e-05	0.000853	CcSEcCtD
Isoniazid—Vomiting—Thiotepa—breast cancer	8.22e-05	0.000853	CcSEcCtD
Isoniazid—Convulsion—Docetaxel—breast cancer	8.19e-05	0.00085	CcSEcCtD
Isoniazid—Paraesthesia—Paclitaxel—breast cancer	8.17e-05	0.000848	CcSEcCtD
Isoniazid—Rash—Thiotepa—breast cancer	8.15e-05	0.000845	CcSEcCtD
Isoniazid—Agranulocytosis—Methotrexate—breast cancer	8.13e-05	0.000844	CcSEcCtD
Isoniazid—Nausea—Vinorelbine—breast cancer	8.04e-05	0.000834	CcSEcCtD
Isoniazid—Dyspepsia—Paclitaxel—breast cancer	8.01e-05	0.000831	CcSEcCtD
Isoniazid—Asthenia—Irinotecan—breast cancer	8.01e-05	0.000831	CcSEcCtD
Isoniazid—Asthenia—Mitoxantrone—breast cancer	8.01e-05	0.000831	CcSEcCtD
Isoniazid—Neuropathy peripheral—Epirubicin—breast cancer	8e-05	0.00083	CcSEcCtD
Isoniazid—Jaundice—Epirubicin—breast cancer	7.95e-05	0.000825	CcSEcCtD
Isoniazid—Decreased appetite—Paclitaxel—breast cancer	7.91e-05	0.000821	CcSEcCtD
Isoniazid—Hypersensitivity—Fluorouracil—breast cancer	7.87e-05	0.000817	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Paclitaxel—breast cancer	7.86e-05	0.000815	CcSEcCtD
Isoniazid—Fatigue—Paclitaxel—breast cancer	7.85e-05	0.000814	CcSEcCtD
Isoniazid—Hepatitis—Methotrexate—breast cancer	7.83e-05	0.000812	CcSEcCtD
Isoniazid—Asthenia—Gemcitabine—breast cancer	7.8e-05	0.000809	CcSEcCtD
Isoniazid—Discomfort—Capecitabine—breast cancer	7.7e-05	0.000799	CcSEcCtD
Isoniazid—Nausea—Thiotepa—breast cancer	7.67e-05	0.000796	CcSEcCtD
Isoniazid—Hyperglycaemia—Doxorubicin—breast cancer	7.64e-05	0.000792	CcSEcCtD
Isoniazid—Agranulocytosis—Epirubicin—breast cancer	7.61e-05	0.00079	CcSEcCtD
Isoniazid—Thrombocytopenia—Docetaxel—breast cancer	7.55e-05	0.000784	CcSEcCtD
Isoniazid—Feeling abnormal—Paclitaxel—breast cancer	7.5e-05	0.000778	CcSEcCtD
Isoniazid—Neuropathy peripheral—Doxorubicin—breast cancer	7.4e-05	0.000768	CcSEcCtD
Isoniazid—Jaundice—Doxorubicin—breast cancer	7.36e-05	0.000763	CcSEcCtD
Isoniazid—Anorexia—Docetaxel—breast cancer	7.35e-05	0.000763	CcSEcCtD
Isoniazid—Hepatitis—Epirubicin—breast cancer	7.32e-05	0.00076	CcSEcCtD
Isoniazid—Thrombocytopenia—Capecitabine—breast cancer	7.31e-05	0.000759	CcSEcCtD
Isoniazid—Body temperature increased—Paclitaxel—breast cancer	7.19e-05	0.000747	CcSEcCtD
Isoniazid—Anorexia—Capecitabine—breast cancer	7.12e-05	0.000739	CcSEcCtD
Isoniazid—Vomiting—Mitoxantrone—breast cancer	7.09e-05	0.000736	CcSEcCtD
Isoniazid—Vomiting—Irinotecan—breast cancer	7.09e-05	0.000736	CcSEcCtD
Isoniazid—Agranulocytosis—Doxorubicin—breast cancer	7.04e-05	0.000731	CcSEcCtD
Isoniazid—Rash—Irinotecan—breast cancer	7.04e-05	0.00073	CcSEcCtD
Isoniazid—Rash—Mitoxantrone—breast cancer	7.04e-05	0.00073	CcSEcCtD
Isoniazid—Paraesthesia—Docetaxel—breast cancer	6.93e-05	0.000719	CcSEcCtD
Isoniazid—Vomiting—Gemcitabine—breast cancer	6.91e-05	0.000717	CcSEcCtD
Isoniazid—Rash—Gemcitabine—breast cancer	6.85e-05	0.000711	CcSEcCtD
Isoniazid—Vomiting—Fluorouracil—breast cancer	6.79e-05	0.000705	CcSEcCtD
Isoniazid—Dyspepsia—Docetaxel—breast cancer	6.79e-05	0.000705	CcSEcCtD
Isoniazid—Hepatitis—Doxorubicin—breast cancer	6.78e-05	0.000703	CcSEcCtD
Isoniazid—Rash—Fluorouracil—breast cancer	6.74e-05	0.000699	CcSEcCtD
Isoniazid—Paraesthesia—Capecitabine—breast cancer	6.71e-05	0.000696	CcSEcCtD
Isoniazid—Decreased appetite—Docetaxel—breast cancer	6.71e-05	0.000696	CcSEcCtD
Isoniazid—Hypersensitivity—Paclitaxel—breast cancer	6.7e-05	0.000696	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Docetaxel—breast cancer	6.66e-05	0.000691	CcSEcCtD
Isoniazid—Fatigue—Docetaxel—breast cancer	6.65e-05	0.00069	CcSEcCtD
Isoniazid—Nausea—Mitoxantrone—breast cancer	6.63e-05	0.000688	CcSEcCtD
Isoniazid—Nausea—Irinotecan—breast cancer	6.63e-05	0.000688	CcSEcCtD
Isoniazid—Dyspepsia—Capecitabine—breast cancer	6.57e-05	0.000682	CcSEcCtD
Isoniazid—Asthenia—Paclitaxel—breast cancer	6.53e-05	0.000678	CcSEcCtD
Isoniazid—Decreased appetite—Capecitabine—breast cancer	6.49e-05	0.000674	CcSEcCtD
Isoniazid—Nausea—Gemcitabine—breast cancer	6.46e-05	0.00067	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Capecitabine—breast cancer	6.45e-05	0.000669	CcSEcCtD
Isoniazid—Fatigue—Capecitabine—breast cancer	6.44e-05	0.000668	CcSEcCtD
Isoniazid—Feeling abnormal—Docetaxel—breast cancer	6.36e-05	0.00066	CcSEcCtD
Isoniazid—Nausea—Fluorouracil—breast cancer	6.35e-05	0.000659	CcSEcCtD
Isoniazid—Ill-defined disorder—Methotrexate—breast cancer	6.32e-05	0.000656	CcSEcCtD
Isoniazid—Feeling abnormal—Capecitabine—breast cancer	6.15e-05	0.000639	CcSEcCtD
Isoniazid—Malaise—Methotrexate—breast cancer	6.14e-05	0.000637	CcSEcCtD
Isoniazid—Body temperature increased—Docetaxel—breast cancer	6.1e-05	0.000633	CcSEcCtD
Isoniazid—Ill-defined disorder—Epirubicin—breast cancer	5.91e-05	0.000614	CcSEcCtD
Isoniazid—Body temperature increased—Capecitabine—breast cancer	5.9e-05	0.000613	CcSEcCtD
Isoniazid—Convulsion—Methotrexate—breast cancer	5.9e-05	0.000612	CcSEcCtD
Isoniazid—Vomiting—Paclitaxel—breast cancer	5.79e-05	0.0006	CcSEcCtD
Isoniazid—Malaise—Epirubicin—breast cancer	5.75e-05	0.000597	CcSEcCtD
Isoniazid—Rash—Paclitaxel—breast cancer	5.74e-05	0.000595	CcSEcCtD
Isoniazid—Discomfort—Methotrexate—breast cancer	5.73e-05	0.000595	CcSEcCtD
Isoniazid—Hypersensitivity—Docetaxel—breast cancer	5.68e-05	0.00059	CcSEcCtD
Isoniazid—Asthenia—Docetaxel—breast cancer	5.53e-05	0.000574	CcSEcCtD
Isoniazid—Convulsion—Epirubicin—breast cancer	5.52e-05	0.000573	CcSEcCtD
Isoniazid—Hypersensitivity—Capecitabine—breast cancer	5.5e-05	0.000571	CcSEcCtD
Isoniazid—Ill-defined disorder—Doxorubicin—breast cancer	5.47e-05	0.000568	CcSEcCtD
Isoniazid—Thrombocytopenia—Methotrexate—breast cancer	5.44e-05	0.000565	CcSEcCtD
Isoniazid—Nausea—Paclitaxel—breast cancer	5.41e-05	0.000561	CcSEcCtD
Isoniazid—Discomfort—Epirubicin—breast cancer	5.36e-05	0.000556	CcSEcCtD
Isoniazid—Asthenia—Capecitabine—breast cancer	5.36e-05	0.000556	CcSEcCtD
Isoniazid—Malaise—Doxorubicin—breast cancer	5.32e-05	0.000552	CcSEcCtD
Isoniazid—Anorexia—Methotrexate—breast cancer	5.3e-05	0.00055	CcSEcCtD
Isoniazid—Convulsion—Doxorubicin—breast cancer	5.11e-05	0.00053	CcSEcCtD
Isoniazid—Thrombocytopenia—Epirubicin—breast cancer	5.09e-05	0.000529	CcSEcCtD
Isoniazid—Paraesthesia—Methotrexate—breast cancer	4.99e-05	0.000518	CcSEcCtD
Isoniazid—Discomfort—Doxorubicin—breast cancer	4.96e-05	0.000515	CcSEcCtD
Isoniazid—Anorexia—Epirubicin—breast cancer	4.96e-05	0.000515	CcSEcCtD
Isoniazid—Vomiting—Docetaxel—breast cancer	4.9e-05	0.000509	CcSEcCtD
Isoniazid—Dyspepsia—Methotrexate—breast cancer	4.89e-05	0.000508	CcSEcCtD
Isoniazid—Rash—Docetaxel—breast cancer	4.86e-05	0.000505	CcSEcCtD
Isoniazid—Decreased appetite—Methotrexate—breast cancer	4.83e-05	0.000502	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Methotrexate—breast cancer	4.8e-05	0.000498	CcSEcCtD
Isoniazid—Fatigue—Methotrexate—breast cancer	4.79e-05	0.000497	CcSEcCtD
Isoniazid—Vomiting—Capecitabine—breast cancer	4.75e-05	0.000493	CcSEcCtD
Isoniazid—Thrombocytopenia—Doxorubicin—breast cancer	4.71e-05	0.000489	CcSEcCtD
Isoniazid—Rash—Capecitabine—breast cancer	4.71e-05	0.000489	CcSEcCtD
Isoniazid—Paraesthesia—Epirubicin—breast cancer	4.67e-05	0.000485	CcSEcCtD
Isoniazid—Anorexia—Doxorubicin—breast cancer	4.59e-05	0.000476	CcSEcCtD
Isoniazid—Nausea—Docetaxel—breast cancer	4.58e-05	0.000475	CcSEcCtD
Isoniazid—Feeling abnormal—Methotrexate—breast cancer	4.58e-05	0.000475	CcSEcCtD
Isoniazid—Dyspepsia—Epirubicin—breast cancer	4.58e-05	0.000475	CcSEcCtD
Isoniazid—Decreased appetite—Epirubicin—breast cancer	4.52e-05	0.000469	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Epirubicin—breast cancer	4.49e-05	0.000466	CcSEcCtD
Isoniazid—Fatigue—Epirubicin—breast cancer	4.49e-05	0.000465	CcSEcCtD
Isoniazid—Nausea—Capecitabine—breast cancer	4.44e-05	0.00046	CcSEcCtD
Isoniazid—Body temperature increased—Methotrexate—breast cancer	4.39e-05	0.000456	CcSEcCtD
Isoniazid—Paraesthesia—Doxorubicin—breast cancer	4.32e-05	0.000449	CcSEcCtD
Isoniazid—Feeling abnormal—Epirubicin—breast cancer	4.29e-05	0.000445	CcSEcCtD
Isoniazid—Dyspepsia—Doxorubicin—breast cancer	4.24e-05	0.00044	CcSEcCtD
Isoniazid—Decreased appetite—Doxorubicin—breast cancer	4.18e-05	0.000434	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Doxorubicin—breast cancer	4.16e-05	0.000431	CcSEcCtD
Isoniazid—Fatigue—Doxorubicin—breast cancer	4.15e-05	0.000431	CcSEcCtD
Isoniazid—Body temperature increased—Epirubicin—breast cancer	4.11e-05	0.000427	CcSEcCtD
Isoniazid—Hypersensitivity—Methotrexate—breast cancer	4.1e-05	0.000425	CcSEcCtD
Isoniazid—Asthenia—Methotrexate—breast cancer	3.99e-05	0.000414	CcSEcCtD
Isoniazid—Feeling abnormal—Doxorubicin—breast cancer	3.97e-05	0.000412	CcSEcCtD
Isoniazid—Hypersensitivity—Epirubicin—breast cancer	3.83e-05	0.000398	CcSEcCtD
Isoniazid—Body temperature increased—Doxorubicin—breast cancer	3.81e-05	0.000395	CcSEcCtD
Isoniazid—Asthenia—Epirubicin—breast cancer	3.73e-05	0.000387	CcSEcCtD
Isoniazid—Hypersensitivity—Doxorubicin—breast cancer	3.55e-05	0.000368	CcSEcCtD
Isoniazid—Vomiting—Methotrexate—breast cancer	3.53e-05	0.000367	CcSEcCtD
Isoniazid—Rash—Methotrexate—breast cancer	3.51e-05	0.000364	CcSEcCtD
Isoniazid—Asthenia—Doxorubicin—breast cancer	3.45e-05	0.000358	CcSEcCtD
Isoniazid—Vomiting—Epirubicin—breast cancer	3.31e-05	0.000343	CcSEcCtD
Isoniazid—Nausea—Methotrexate—breast cancer	3.3e-05	0.000343	CcSEcCtD
Isoniazid—Rash—Epirubicin—breast cancer	3.28e-05	0.00034	CcSEcCtD
Isoniazid—Nausea—Epirubicin—breast cancer	3.09e-05	0.000321	CcSEcCtD
Isoniazid—Vomiting—Doxorubicin—breast cancer	3.06e-05	0.000318	CcSEcCtD
Isoniazid—Rash—Doxorubicin—breast cancer	3.04e-05	0.000315	CcSEcCtD
Isoniazid—Nausea—Doxorubicin—breast cancer	2.86e-05	0.000297	CcSEcCtD
Isoniazid—CYP2D6—Metabolism—BCHE—breast cancer	3.31e-06	4.56e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—HBA1—breast cancer	3.29e-06	4.54e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—FASN—breast cancer	3.29e-06	4.54e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—CYP1B1—breast cancer	3.29e-06	4.53e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—BCHE—breast cancer	3.28e-06	4.52e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—SLC5A5—breast cancer	3.27e-06	4.5e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—GPX1—breast cancer	3.26e-06	4.5e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.25e-06	4.48e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—SLC5A5—breast cancer	3.24e-06	4.46e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—IDH1—breast cancer	3.24e-06	4.46e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GSTA1—breast cancer	3.24e-06	4.46e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—CYP1A1—breast cancer	3.23e-06	4.45e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—HSP90AA1—breast cancer	3.23e-06	4.45e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—COMT—breast cancer	3.22e-06	4.44e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—GSTT1—breast cancer	3.22e-06	4.43e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ACHE—breast cancer	3.22e-06	4.43e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—GSTP1—breast cancer	3.21e-06	4.42e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—ERCC2—breast cancer	3.2e-06	4.42e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PIK3CG—breast cancer	3.2e-06	4.41e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—NAT2—breast cancer	3.2e-06	4.41e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—HMOX1—breast cancer	3.16e-06	4.36e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—NQO1—breast cancer	3.15e-06	4.35e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—SLC2A1—breast cancer	3.15e-06	4.35e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—ITPR1—breast cancer	3.15e-06	4.35e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—NCOA1—breast cancer	3.14e-06	4.32e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—NQO1—breast cancer	3.13e-06	4.31e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—SLC2A1—breast cancer	3.13e-06	4.31e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—STK11—breast cancer	3.09e-06	4.26e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—CYP19A1—breast cancer	3.09e-06	4.26e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CYP3A4—breast cancer	3.08e-06	4.24e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.06e-06	4.22e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CYP3A4—breast cancer	3.05e-06	4.2e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CYP17A1—breast cancer	3.04e-06	4.2e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.03e-06	4.18e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—ABCB1—breast cancer	3.03e-06	4.18e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CYP1B1—breast cancer	3.02e-06	4.17e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ENO1—breast cancer	3.01e-06	4.15e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PTGS1—breast cancer	3.01e-06	4.15e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—MTHFR—breast cancer	3.01e-06	4.15e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	3e-06	4.14e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CYP1B1—breast cancer	3e-06	4.13e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—TYMS—breast cancer	2.98e-06	4.11e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—HSP90AA1—breast cancer	2.97e-06	4.09e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.96e-06	4.09e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CYP2D6—breast cancer	2.96e-06	4.07e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PLA2G4A—breast cancer	2.95e-06	4.06e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—NCOR1—breast cancer	2.95e-06	4.06e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—GSTM1—breast cancer	2.95e-06	4.06e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—HSP90AA1—breast cancer	2.94e-06	4.05e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.9e-06	4e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—NCOA2—breast cancer	2.9e-06	4e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—NCOA1—breast cancer	2.89e-06	3.98e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—COMT—breast cancer	2.87e-06	3.96e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—GSTP1—breast cancer	2.86e-06	3.94e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—NCOA1—breast cancer	2.86e-06	3.94e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—STK11—breast cancer	2.84e-06	3.92e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CYP19A1—breast cancer	2.84e-06	3.92e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—HMOX1—breast cancer	2.82e-06	3.89e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—GPX1—breast cancer	2.82e-06	3.89e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CYP19A1—breast cancer	2.82e-06	3.89e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—STK11—breast cancer	2.82e-06	3.89e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—ITPR1—breast cancer	2.82e-06	3.88e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PIK3CD—breast cancer	2.81e-06	3.88e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—FASN—breast cancer	2.81e-06	3.88e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—MED12—breast cancer	2.81e-06	3.87e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—DPYD—breast cancer	2.81e-06	3.87e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—BCHE—breast cancer	2.8e-06	3.86e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—CYP1A1—breast cancer	2.79e-06	3.85e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—ALB—breast cancer	2.78e-06	3.83e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—CAV1—breast cancer	2.78e-06	3.83e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—ERCC2—breast cancer	2.77e-06	3.82e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—SLC5A5—breast cancer	2.77e-06	3.81e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ALDOA—breast cancer	2.76e-06	3.81e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—ABCB1—breast cancer	2.71e-06	3.73e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—NCOA3—breast cancer	2.68e-06	3.7e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—SLC2A1—breast cancer	2.67e-06	3.68e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—NQO1—breast cancer	2.67e-06	3.68e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—SLC2A2—breast cancer	2.66e-06	3.67e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—TYMS—breast cancer	2.66e-06	3.67e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—NOS3—breast cancer	2.66e-06	3.66e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.65e-06	3.65e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—COMT—breast cancer	2.64e-06	3.64e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—GSTP1—breast cancer	2.63e-06	3.63e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—GSTM1—breast cancer	2.63e-06	3.62e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—NCOR1—breast cancer	2.63e-06	3.62e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PLA2G4A—breast cancer	2.63e-06	3.62e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—COMT—breast cancer	2.62e-06	3.61e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.62e-06	3.61e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—MTR—breast cancer	2.61e-06	3.6e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CPT1A—breast cancer	2.61e-06	3.6e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ABCG2—breast cancer	2.61e-06	3.6e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—GSTP1—breast cancer	2.61e-06	3.6e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CYP3A4—breast cancer	2.61e-06	3.59e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—MTHFR—breast cancer	2.6e-06	3.59e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—HMOX1—breast cancer	2.6e-06	3.58e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.59e-06	3.57e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—ITPR1—breast cancer	2.59e-06	3.57e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—HMOX1—breast cancer	2.57e-06	3.55e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—ITPR1—breast cancer	2.57e-06	3.54e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CYP1B1—breast cancer	2.56e-06	3.53e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—HPGDS—breast cancer	2.56e-06	3.53e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—HBA1—breast cancer	2.54e-06	3.51e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PIK3CG—breast cancer	2.53e-06	3.49e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—GPX1—breast cancer	2.52e-06	3.47e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—HSP90AA1—breast cancer	2.51e-06	3.46e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—CYP1A1—breast cancer	2.49e-06	3.44e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—ABCB1—breast cancer	2.49e-06	3.43e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ACHE—breast cancer	2.48e-06	3.42e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GSTT1—breast cancer	2.48e-06	3.42e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—ERCC2—breast cancer	2.47e-06	3.41e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—ABCB1—breast cancer	2.47e-06	3.4e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PIK3CB—breast cancer	2.45e-06	3.38e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—TYMS—breast cancer	2.45e-06	3.37e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—NCOA1—breast cancer	2.44e-06	3.37e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PTGS2—breast cancer	2.43e-06	3.35e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—TYMS—breast cancer	2.43e-06	3.34e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—GSTM1—breast cancer	2.42e-06	3.33e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PLA2G4A—breast cancer	2.42e-06	3.33e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—NCOR1—breast cancer	2.42e-06	3.33e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CYP19A1—breast cancer	2.41e-06	3.32e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—STK11—breast cancer	2.41e-06	3.32e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—CAV1—breast cancer	2.4e-06	3.31e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PLA2G4A—breast cancer	2.4e-06	3.3e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—NCOR1—breast cancer	2.4e-06	3.3e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—GSTM1—breast cancer	2.4e-06	3.3e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CYP17A1—breast cancer	2.35e-06	3.24e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PTGS1—breast cancer	2.33e-06	3.21e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ENO1—breast cancer	2.33e-06	3.21e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—MTHFR—breast cancer	2.32e-06	3.2e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—GPX1—breast cancer	2.32e-06	3.19e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—GPX1—breast cancer	2.3e-06	3.16e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.29e-06	3.16e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CYP1A1—breast cancer	2.29e-06	3.16e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CYP2D6—breast cancer	2.28e-06	3.14e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—ERCC2—breast cancer	2.27e-06	3.13e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CYP1A1—breast cancer	2.27e-06	3.13e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.26e-06	3.12e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—ERCC2—breast cancer	2.25e-06	3.11e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—COMT—breast cancer	2.24e-06	3.09e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—NCOA2—breast cancer	2.24e-06	3.09e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—GSTP1—breast cancer	2.23e-06	3.07e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PIK3CD—breast cancer	2.22e-06	3.07e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—HMOX1—breast cancer	2.2e-06	3.03e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—ALB—breast cancer	2.2e-06	3.03e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ITPR1—breast cancer	2.19e-06	3.02e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PIK3CG—breast cancer	2.19e-06	3.01e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—FASN—breast cancer	2.17e-06	2.99e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—BCHE—breast cancer	2.16e-06	2.98e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—CAV1—breast cancer	2.14e-06	2.95e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—MTHFR—breast cancer	2.14e-06	2.95e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—SLC5A5—breast cancer	2.14e-06	2.94e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PTEN—breast cancer	2.12e-06	2.92e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—MTHFR—breast cancer	2.12e-06	2.92e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ABCB1—breast cancer	2.11e-06	2.91e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—NOS3—breast cancer	2.1e-06	2.9e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—TYMS—breast cancer	2.07e-06	2.86e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—NQO1—breast cancer	2.06e-06	2.84e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—SLC2A1—breast cancer	2.06e-06	2.84e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PLA2G4A—breast cancer	2.05e-06	2.82e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—GSTM1—breast cancer	2.05e-06	2.82e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—NCOR1—breast cancer	2.05e-06	2.82e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.05e-06	2.82e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CYP1B1—breast cancer	1.98e-06	2.73e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CAV1—breast cancer	1.97e-06	2.72e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—GPX1—breast cancer	1.96e-06	2.7e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CAV1—breast cancer	1.95e-06	2.69e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PIK3CG—breast cancer	1.95e-06	2.69e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CYP1A1—breast cancer	1.94e-06	2.68e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.94e-06	2.67e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PIK3CB—breast cancer	1.94e-06	2.67e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ERCC2—breast cancer	1.93e-06	2.66e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PIK3CD—breast cancer	1.92e-06	2.65e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PTGS2—breast cancer	1.92e-06	2.65e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—ALB—breast cancer	1.9e-06	2.62e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—NCOA1—breast cancer	1.89e-06	2.6e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.87e-06	2.57e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—STK11—breast cancer	1.86e-06	2.56e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CYP19A1—breast cancer	1.86e-06	2.56e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—NOS3—breast cancer	1.82e-06	2.5e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—MTHFR—breast cancer	1.81e-06	2.5e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PIK3CG—breast cancer	1.8e-06	2.48e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PIK3CG—breast cancer	1.78e-06	2.45e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—COMT—breast cancer	1.73e-06	2.38e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GSTP1—breast cancer	1.72e-06	2.37e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PIK3CD—breast cancer	1.72e-06	2.37e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—HMOX1—breast cancer	1.7e-06	2.34e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—ALB—breast cancer	1.69e-06	2.34e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ITPR1—breast cancer	1.69e-06	2.33e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PIK3CB—breast cancer	1.68e-06	2.31e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PTEN—breast cancer	1.68e-06	2.31e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CAV1—breast cancer	1.67e-06	2.3e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PTGS2—breast cancer	1.66e-06	2.29e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ABCB1—breast cancer	1.63e-06	2.24e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—NOS3—breast cancer	1.62e-06	2.23e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—TYMS—breast cancer	1.6e-06	2.2e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.6e-06	2.2e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GSTM1—breast cancer	1.58e-06	2.18e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—NCOR1—breast cancer	1.58e-06	2.18e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.58e-06	2.18e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PIK3CD—breast cancer	1.58e-06	2.18e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PIK3CD—breast cancer	1.56e-06	2.16e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—ALB—breast cancer	1.56e-06	2.15e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—ALB—breast cancer	1.54e-06	2.13e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PIK3CG—breast cancer	1.52e-06	2.1e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GPX1—breast cancer	1.51e-06	2.09e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CYP1A1—breast cancer	1.5e-06	2.07e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PIK3CB—breast cancer	1.5e-06	2.06e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PIK3CA—breast cancer	1.5e-06	2.06e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—NOS3—breast cancer	1.49e-06	2.05e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ERCC2—breast cancer	1.49e-06	2.05e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PTGS2—breast cancer	1.48e-06	2.04e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—NOS3—breast cancer	1.48e-06	2.04e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PTEN—breast cancer	1.45e-06	2e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—MTHFR—breast cancer	1.4e-06	1.93e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PIK3CB—breast cancer	1.38e-06	1.9e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PIK3CB—breast cancer	1.36e-06	1.88e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PTGS2—breast cancer	1.36e-06	1.88e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PTGS2—breast cancer	1.35e-06	1.86e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PIK3CD—breast cancer	1.34e-06	1.84e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ALB—breast cancer	1.32e-06	1.82e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PTEN—breast cancer	1.29e-06	1.78e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CAV1—breast cancer	1.29e-06	1.78e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—NOS3—breast cancer	1.26e-06	1.74e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—AKT1—breast cancer	1.22e-06	1.68e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PTEN—breast cancer	1.19e-06	1.64e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PIK3CA—breast cancer	1.18e-06	1.63e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PTEN—breast cancer	1.18e-06	1.62e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PIK3CG—breast cancer	1.17e-06	1.62e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PIK3CB—breast cancer	1.17e-06	1.61e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PTGS2—breast cancer	1.15e-06	1.59e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PIK3CD—breast cancer	1.03e-06	1.42e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PIK3CA—breast cancer	1.02e-06	1.41e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ALB—breast cancer	1.02e-06	1.4e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PTEN—breast cancer	1.01e-06	1.39e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—NOS3—breast cancer	9.75e-07	1.34e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—AKT1—breast cancer	9.66e-07	1.33e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PIK3CA—breast cancer	9.12e-07	1.26e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PIK3CB—breast cancer	9e-07	1.24e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PTGS2—breast cancer	8.91e-07	1.23e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PIK3CA—breast cancer	8.39e-07	1.16e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—AKT1—breast cancer	8.35e-07	1.15e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PIK3CA—breast cancer	8.31e-07	1.15e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PTEN—breast cancer	7.77e-07	1.07e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—AKT1—breast cancer	7.45e-07	1.03e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PIK3CA—breast cancer	7.11e-07	9.79e-06	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—AKT1—breast cancer	6.85e-07	9.44e-06	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—AKT1—breast cancer	6.79e-07	9.36e-06	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—AKT1—breast cancer	5.8e-07	8e-06	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PIK3CA—breast cancer	5.48e-07	7.56e-06	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—AKT1—breast cancer	4.48e-07	6.18e-06	CbGpPWpGaD
